$0.1050
0.003503.45%
At close: -
$0.1051
0.000100.10%
After Hours: 7:59 PM EDT
BioLine Rx reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of BioLine Rx using advanced sorting and filters.
Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Q3 | 2024-11-25 | $-0.07 | $-0.10 | 30.0 % |
Q2 | 2024-08-15 | $0 | $-0.14 | 100.0 % |
Q1 | 2024-05-28 | $-0.01 | $-0.29 | 96.5 % |
Q3 | 2023-11-20 | $-0.26 | $-0.21 | -23.8 % |
Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Q3 | 2024-11-25 | $4.94M | $4.12M | 20.0 % |
Q2 | 2024-08-15 | $5.39M | $3.93M | 37.2 % |
BioLine Rx (BLRX) is scheduled to report earnings on March 25, 2025. The last reported earnings were for reported on November 25, 2024 for Q3.
The Actual EPS was $-0.07, which beat the estimate of $-0.10.
The Actual Revenue was $4.9M, which beat the estimate of $4.1M.
Browse earnings estimates, EPS, and revenue on all stocks.